Title: Marketing Planning for Caliper Technologies
1Marketing Planning for Caliper Technologies
Labchips
- Mgmt. 266A Product Management (Cooper)
- William Fang, Greg Kim, Bryant Kong,Simon Male,
Rohit Talwani - March 13, 2002
2Planning Objective
- To determine the likelihood of various levels of
revenue growth for Caliper Technologies labchip
product line over the coming year.
3Agenda
- What Are Labchips?
- Caliper Technologies
- Market Overview
- Critical Issues
- Hugin Network
- Probabilities
- Results and Decision Nodes
- Sensitivity Analysis
- Recommendations
- Questions?
4What Are Labchips?
- Labchips are miniature silicon devices used for
biomedical applications on a micro-dimensional
scale - Use MicroElectroMechanical systems (MEMS)
technology - Can reduce duration of experiments by orders
of magnitude - Automate previously manual laboratory processes
- Require much smaller amounts of sample and
reagents - Offer mission-critical benefits to researchers
- Faster throughput
- Cost savings
- Reduced human error
5Caliper Technologies
- Public biotechnology company with 32 M in
revenues from two main sources - Labchips and Agilent analyzer system (est. 19.2
M) - High-throughput screening systems
- Labchip systems are used in chemistry,
biomedical research, and drug discovery and
development - DNA, RNA, protein, and cell analysis
- Market leader in labchips
- Principal strategic partner is Agilent
Technologies - Uses lead customer programs to identify new
product applications - Recently settled patent litigation with
competitor ACLARA
6Market Overview
- Labchip market estimated at 300 M in 2000
- Projected annual growth rates of 30-40
- Early stages of development
- Fragmented competition
- Public labchip companies ACLARA, Cepheid,
Nanogen, Orchid - Large bioscience players Applied Biosystems,
IBM, Motorola - Private companies Many players
- Acadamic and government instiutitions MIT,
Dept. of Defense - Significant market trends
- Escalating RD costs, expiring patents drive
customer need - Intellectual property battles patent
litigation or cross-licensing - Lack of technology standards
7Critical Issues
- Derived from preceding market analysis
- Also regulatory, manufacturing, social and
behavioral issues - Affect research applications or future uses of
labchips
8Hugin Network
Internal Economics
Demand
Product Design
Customer Need
Competition
Product Success
Major Forces
Regulation
9Internal Economics
- Technical factors dictate product complexity and
manufacturing cost - Combined with pricing decision, this determines
Calipers margins
Standards
Customization
High Medium Low
Leader Follower
Micro-dimensional Constraints
Product Design
Inter-operability
Problematic Not a Problem
Yes No
Complex Moderate Simple
Manufacturing Cost
Demand
Price
Not Costly Costly Very Costly
Low Medium High
Low Medium High
Margins
Product Success
Good Acceptable Poor
10Demand
Aging Population
- Primary driver of demand is labchips ability to
meet customer needs - Secondary driver of demand is value-based price
of product
Growing Plateauing
Process Change
Government Funding
Significant Medium Insignificant
High Medium Low
Inter-operability
Customer Need
RD Cost
Patent Expiration
High Impact Low Impact
Rising Plateauing
Yes No
High Medium Low
Demand
Price
Low Medium High
High Medium Low
Product Success
11Competition
Patent Litigation
- Strategic partnerships and cross-licensing
determine degree of competition - Intensity of competition directly impacts
Calipers margins
IntenseFew
Cross-Licensing
HighMediumLow
ManyModerateFew
Strategic Partnerships
Competition
IntenseModerateLittle
Margin
12Regulation Can Hinder Growth
- Regulation and low access to capital can slow
Calipers growth
Access to Capital
Bull Market Bear Market
FDA
Approval Rejection
Product Success
Regulation
International
FavorableUnfavorable
ApprovalUnfavorable
13Four Major Forces Impact Product Success
Demand
Price
High Medium Low
Access to Capital
Competition
High Medium Low
Bull Market Bear Market
Margin
Product Success
Regulation
Favorable Unfavorable
Good Acceptable Poor
High Medium Low
Utility (Revenues)
High 30.7 M (60 growth) Medium 25.0 M (30
growth) Low 21.1 M (10 growth)
14Estimating Probabilities
- Probabilities for starting nodes were
straightforward - No other nodes influencing them
- Probabilities for nodes with inputs were more
difficult. We - Decided the order of strength in which input
nodes influence the node - Arranged in ordinal orders each probability set
- Determined the graphical behavior of the
probability - Assigned probabilities
15Demand Example
Customer Need has a larger influence on Demand.
So we ordered each permutation and set the two
extreme values.
We then determined the graph of the probability
appears as follows
16Demand Example continued
Then we interpolate the in-between values to
complete the table
17Results and Decision Nodes
- Calipers expected labchip revenues are 24.9 M
18Sensitivity Analysis
19Recommendations
- Caliper should focus on the factors that most
strongly influence product success - Build customer demand
- Lobby for favorable regulations
- Caliper should use its lead customer programs to
identify and develop labchip applications that
are widely valued in its beachhead market - Risk of building too many customized applications
- Could get stuck in early market forever
- Need to cross chasm with application that will
enable company to dominate pharmaceutical market
20Questions?